These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17194821)

  • 1. In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.
    Torres-Narbona M; Guinea J; Martínez-Alarcón J; Peláez T; Bouza E
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1126-9. PubMed ID: 17194821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
    Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
    Lacroix C; de Chauvin MF
    J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Morace G; Drago M; Scaltrito MM; Conti S; Fanti F; Polonelli L;
    J Chemother; 2007 Oct; 19(5):508-13. PubMed ID: 18073149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole.
    Patel R; Mendrick C; Knapp CC; Grist R; McNicholas PM
    J Clin Microbiol; 2007 Jun; 45(6):2000-1. PubMed ID: 17428931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Sensititre YeastOne® dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains.
    Bertout S; Dunyach C; Drakulovski P; Reynes J; Mallié M
    Pathol Biol (Paris); 2011 Feb; 59(1):48-51. PubMed ID: 20843616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Canton E
    J Clin Microbiol; 2008 May; 46(5):1793-803. PubMed ID: 18337384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
    Kondori N; Svensson E; Mattsby-Baltzer I
    Mycoses; 2011 Sep; 54(5):e318-22. PubMed ID: 20557462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of 100 filamentous fungi: comparison of two diffusion methods, Neo-Sensitabs and E-test, for amphotericin B, caspofungin, itraconazole, voriconazole and posaconazole.
    Colosi IA; Faure O; Dessaigne B; Bourdon C; Lebeau B; Colosi HA; Pelloux H
    Med Mycol; 2012 May; 50(4):378-85. PubMed ID: 21981028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Sensititre YeastOne
    Chang W; Bao F; Wang Z; Liu H; Zhang F
    Mycoses; 2021 Jul; 64(7):734-741. PubMed ID: 33760301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.
    Sun QN; Fothergill AW; McCarthy DI; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 2002 May; 46(5):1581-2. PubMed ID: 11959605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    Espinel-Ingroff A; Johnson E; Hockey H; Troke P
    J Antimicrob Chemother; 2008 Mar; 61(3):616-20. PubMed ID: 18222957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of dematiaceous fungi to nine antifungal agents determined by two different methods.
    Zheng H; He Y; Kan S; Li D; Lv G; Shen Y; Mei H; Li X; Liu W
    Mycoses; 2019 Apr; 62(4):384-390. PubMed ID: 30663811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against
    Melhem MSC; Coelho VC; Fonseca CA; Oliveira L; Bonfietti LX; Szeszs MW; Magri MMC; Dorneles FS; Taguchi H; Moreira DVS; Motta AL; Batista MV; Kamei K; Shikanai-Yasuda MA
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.